Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding

9 Jan 2018

Abstract excerpt

Current therapeutic antibodies such as Trastuzumab, are typically of the blood circulatory IgG1 class (Cκ/ CHγ1). Due to the binding to Her2 also present on normal cell surfaces, side effects such as cardiac failure can sometimes be associated with such targeted therapy. Using antibody isotype swapping, it may be possible to reduce systemic circulation through increased tissue localization, thereby minimising...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HER2/EGFR in Cancer Research
Share to Monoclonal and Polyclonal Antibodies Research
Share to Protein purification and stability

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29335579
DOI: 10.1038/s41598-017-18892-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-bindingPMID 29335579Read ↗

Impact of Light Chain Variants on the Expression of Therapeutic Monoclonal Antibodies in HEK293 and CHO CellsSemantic proximity Read ↗

Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-LifeSemantic proximity Read ↗

Profiling the Biophysical Developability Properties of Common IgG1 Fc Effector Silencing VariantsSemantic proximity Read ↗

Antibody Structure and Function: The Basis for Engineering TherapeuticsSemantic proximity Read ↗

Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen BindingSemantic proximity Read ↗

Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen BindingSemantic proximity Read ↗

Antibody light chain variable domains and their biophysically improved versions for human immunotherapySemantic proximity Read ↗

Effect of the ADCC-Modulating Mutations and the Selection of Human IgG Isotypes on Physicochemical Properties of Fc.Semantic proximity Read ↗

Not all therapeutic antibody isotypes are equal: the case of IgM versus IgG in Pertuzumab and TrastuzumabSemantic proximity Read ↗

The Influence of Variable-Heavy (V <sub>H</sub> ) Chain Families on IgG <sub>2</sub> , <sub>3</sub> , <sub>4</sub> on FcγRs and Antibody Superantigens Protein G and L Binding using Biolayer InterferometrySemantic proximity Read ↗

Antibody therapeutics:Semantic proximity Read ↗

Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-Cλ interface.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.